CHC
Charter Hall Group
🇦🇺 ASX
🕊️ SOCIALLY AWARE
📈 HIGH PRICE GROWTH
🏠 REAL ESTATE
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 9.18%
Annual Growth
5 years average annual growth
💰
3.86%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
46
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Charter Hall Group engages in managing and investing in office, retail, and industrial properties. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-06-10. The firm operates a diverse portfolio of quality properties across core sectors, such as office, industrial and logistics, retail, and social infrastructure. The company operates through three segments: Property investments, Development investments, and Funds management. Property investments segment is comprised of investments in property funds. Development investments comprises investments in developments. Funds management comprises investment management services and property management services. The company owns and manages various properties across Australia, from landmark city offices and industrial and logistics facilities to local shopping centers and early learning centers. Its properties include 10 Shelley Street, 132-170 Andrews Rd, 6 Stewart Ave, 61 Mary Street, CoreWest Logistics Hub, Dandenong Distribution Centre, Edinburgh Parks Distribution Centre, No.1 Martin Place, and Pacific Square Shopping.
📈 Performance
Price History
+245.67%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
3.86%
💰 Annual Dividend Earnings Per $1,000 invested**
$38.57
💰 Most Recent Dividend Franked Percentage Estimate
90.00%
💰 Average Dividend Franked Percentage Estimate
44.89 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of CHC, your last dividend payment(s) would have been:
$ 261.03
on Fri Aug 30 2024
$ 218.67
on Thu Feb 29 2024
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.45
90.00%
2023
$0.43
44.99%
2022
$0.40
45.00%
2021
$0.38
42.37%
2020
$0.36
40.16%
2019
$0.34
17.14%
2018
$0.32
49.69%
2017
$0.30
39.74%
2016
$0.27
0.00%
2015
$0.24
0.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
81
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
46
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$15.55
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CHC
46
📊 Total Capital Earnings
$168K
🔃 Average investment frequency
30 weeks
💵 Average investment amount
$3,197
⏰ Last time a customer invested in CHC
2 hours
CHC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
29%
50k - 100k
22%
Less than 50k
40%
👶 Age of investors
18 - 25
11%
26 - 34
33%
35 - 90
57%
🙋 Legal gender of investors
Female
50%
Male
50%
Pearlers who invest in CHC also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
4.43%
📊 Share price
$104.33 AUD
🧱 MATERIALS
⛳️ DIVERSIFIED
💸 FINANCIALS
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
4.09%
📊 Share price
$68.57 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
19.73%
📊 Share price
$61.01 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
13.28%
📊 Share price
$134.96 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
25.70%
📊 Share price
$47.39 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
Want more shares? Try these...
Camplify Holdings Ltd. operates in the RV rental market. The firm has built a platform that delivers transparent experiences for consumers and RV hirers to connect with RV owners and small and medium-sized enterprises (SMEs) with a fleet of RVs. Its businesses include Camplify and PaulCamper. Its segments include Hire, Membership and Other. The firm provides a range of caravans, motorhomes, camper trailers and campervans for hire via the respective platforms. The firm has operations in Australia, New Zealand, Spain, United Kingdom, Germany, Austria and Netherlands. Its subsidiaries include Camplify Co (Australia) Pty Ltd, Camplify Co (NZ) Limited, Camplify Co (UK) Limited, Plataforma Camplify Espana, S.L and PaulCamper GmbH.
📊 Share price
$0.90 AUD
🛤️ TRANSPORTATION INFRASTRUCTURE
Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. The firm is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The firm is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.
📊 Share price
$0.01 AUD
🧬 BIOTECHNOLOGY
CGS
Cogstate Ltd. is a global cognitive science company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-02-13. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
🙌 Performance (5Yr p.a)
29.50%
📊 Share price
$0.99 AUD
📈 HIGH PRICE GROWTH
🩺 HEALTH CARE
🕊️
Social Score
99
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.